Liquid-biopsy transcriptomic profiling uncovers molecular mediators of resistance to androgen receptor signaling inhibition in lethal prostate cancer is a research paper published in medRxiv (2021). On theSindex it has a DataRank of 0. It has been cited 2 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: 1R01CA233585-01
Targeting convergent oncogenic signaling during AR inhibition to overcome metastasis and immune evasion in prostate cancer
National Institutes of Health
Grant: 5UL1TR002384-03
Clinical and Translational Science Center
National Institutes of Health
Grant: 5T32CA062948-09
CANCER PHARMACOLOGY
National Institutes of Health
Grant: 1R21CA216800-01A1
Biomarkers of taxane chemotherapy response/resistance in prostate cancer
National Institutes of Health
Grant: 5R01CA179100-02
Mechanistic Insights Underlying ERG-induced Taxane Resistance in Castration-Resis
National Institutes of Health
Grant: 5P30CA014236-30
COMPREHENSIVE CANCER CENTER CORE SUPPORT GRANT
National Institutes of Health
Grant: 5R01CA137020-03
Microtubule dependent AR signaling predicts taxane sensitivity
National Institutes of Health
Grant: 1T32CA203702-01A1
Molecular and Translational Oncology Research
Fields of Study
Sustainable Development Goals